Search Tag: ECCMID
2019 10 Apr
Data will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panels—positively impact patients with bloodstream infections. LEXINGTON, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development of innovative medical diagnostic products...Read more
2014 10 May
24th ECCMID 2014 For the 24th edition of ECCMID, the Program Committee has prepared for a series of keynote lectures, symposium, educational workshops and meet-the-expert sessions on parallel tracks, covering the entire field of infectious diseases and clinical microbiology. Read more